<?xml version="1.0" encoding="UTF-8"?><rss version="2.0" xmlns:content="http://purl.org/rss/1.0/modules/content/"><channel><title>老汉和新药 | wechat-feeds</title><link>http://MzIyOTU2NjQ0OA.favicon.privacyhide.com/favicon.ico</link><description>一篇文章，一场报告，一则新闻，以小见大，有感而发，聊一聊新药R&amp;D (一家之言，不定期更新)...</description><managingEditor> (hellodword)</managingEditor><pubDate>Mon, 25 Jan 2021 23:40:57 +0800</pubDate><image><url>http://MzIyOTU2NjQ0OA.favicon.privacyhide.com/favicon.ico</url><title>老汉和新药 | wechat-feeds</title><link>http://MzIyOTU2NjQ0OA.favicon.privacyhide.com/favicon.ico</link><width>64</width><height>64</height></image><item><title>Menin抑制剂KO-539</title><link>https://mp.weixin.qq.com/s/Gv_jm84kqZhnYmQufrFKug</link><description></description><content:encoded><![CDATA[Menin抑制剂KO-539]]></content:encoded><pubDate>Tue, 10 Nov 2020 14:08:29 +0800</pubDate></item><item><title>JAK1抑制剂Abrocitinib</title><link>https://mp.weixin.qq.com/s/OaqrzNd1Tn4GnPE01IYqEA</link><description></description><content:encoded><![CDATA[JAK1抑制剂Abrocitinib]]></content:encoded><pubDate>Tue, 03 Nov 2020 15:33:01 +0800</pubDate></item><item><title>CDK4/6抑制剂</title><link>https://mp.weixin.qq.com/s/ZAJM5iMYmSUQCBLkpe8UJg</link><description></description><content:encoded><![CDATA[CDK4/6抑制剂]]></content:encoded><pubDate>Fri, 30 Oct 2020 17:08:42 +0800</pubDate></item><item><title>AMG510 vs MRTX849：Part 2</title><link>https://mp.weixin.qq.com/s/zejInIB2O3wR-gaWiHeCDQ</link><description></description><content:encoded><![CDATA[AMG510 vs MRTX849：Part 2]]></content:encoded><pubDate>Wed, 28 Oct 2020 11:58:58 +0800</pubDate></item><item><title>AMG510 vs MRTX849</title><link>https://mp.weixin.qq.com/s/QzcfIIVpEp72zl1obfpyqg</link><description></description><content:encoded><![CDATA[AMG510 vs MRTX849]]></content:encoded><pubDate>Mon, 26 Oct 2020 17:54:16 +0800</pubDate></item><item><title>RMC-4630更新：就这？</title><link>https://mp.weixin.qq.com/s/zacersq9Q_JVmq2kjNEeGQ</link><description></description><content:encoded><![CDATA[RMC-4630更新：就这？]]></content:encoded><pubDate>Sun, 25 Oct 2020 11:41:39 +0800</pubDate></item><item><title>FGFR抑制剂Futibatinib</title><link>https://mp.weixin.qq.com/s/-AlbWdjUEzTcKlyw_hie5A</link><description></description><content:encoded><![CDATA[FGFR抑制剂Futibatinib]]></content:encoded><pubDate>Sat, 24 Oct 2020 18:41:03 +0800</pubDate></item><item><title>EZH2抑制剂Tazemetostat</title><link>https://mp.weixin.qq.com/s/A93Tpe6iGgBn1hCMeXWfOQ</link><description></description><content:encoded><![CDATA[EZH2抑制剂Tazemetostat]]></content:encoded><pubDate>Wed, 21 Oct 2020 17:40:15 +0800</pubDate></item><item><title>Efruxifermin获PRIME认证</title><link>https://mp.weixin.qq.com/s/Pjc3zRkhUkfQOaktOGIZrg</link><description></description><content:encoded><![CDATA[Efruxifermin获PRIME认证]]></content:encoded><pubDate>Mon, 19 Oct 2020 19:25:35 +0800</pubDate></item><item><title>AKT抑制剂Ipatasertib</title><link>https://mp.weixin.qq.com/s/FZDi0Q5UUwn6x3y5wd93vA</link><description></description><content:encoded><![CDATA[AKT抑制剂Ipatasertib]]></content:encoded><pubDate>Fri, 16 Oct 2020 22:40:44 +0800</pubDate></item></channel></rss>